GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (NAS:IDXX) » Definitions » PS Ratio

IDEXX Laboratories (IDEXX Laboratories) PS Ratio

: 10.93 (As of Today)
View and export this data going back to 1991. Start your Free Trial

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, IDEXX Laboratories's share price is $476.35. IDEXX Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $43.60. Hence, IDEXX Laboratories's PS Ratio for today is 10.93.

The historical rank and industry rank for IDEXX Laboratories's PS Ratio or its related term are showing as below:

IDXX' s PS Ratio Range Over the Past 10 Years
Min: 3.54   Med: 8.64   Max: 19.77
Current: 10.93

During the past 13 years, IDEXX Laboratories's highest PS Ratio was 19.77. The lowest was 3.54. And the median was 8.64.

IDXX's PS Ratio is ranked worse than
83.33% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.85 vs IDXX: 10.93

IDEXX Laboratories's Revenue per Sharefor the three months ended in Dec. 2023 was $10.74. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $43.60.

Good Sign:

IDEXX Laboratories Inc has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of IDEXX Laboratories was 9.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 11.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 12.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 13.20% per year.

During the past 13 years, IDEXX Laboratories's highest 3-Year average Revenue per Share Growth Rate was 35.60% per year. The lowest was 8.40% per year. And the median was 13.45% per year.

Back to Basics: PS Ratio


IDEXX Laboratories PS Ratio Historical Data

The historical data trend for IDEXX Laboratories's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => 9.50 [6] => 16.02 [7] => 17.73 [8] => 10.25 [9] => 12.73 )
IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.50 16.02 17.73 10.25 12.73

IDEXX Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.25 12.27 12.00 10.23 12.73

Competitive Comparison

For the Diagnostics & Research subindustry, IDEXX Laboratories's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories PS Ratio Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's PS Ratio distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's PS Ratio falls into.



IDEXX Laboratories PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

IDEXX Laboratories's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=476.35/43.599
=10.93

IDEXX Laboratories's Share Price of today is $476.35.
IDEXX Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $43.60.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


IDEXX Laboratories  (NAS:IDXX) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


IDEXX Laboratories PS Ratio Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (IDEXX Laboratories) Business Description

Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.
Executives
James F Polewaczyk officer: Corporate Vice President IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Jonathan Jay Mazelsky director, officer: President and CEO ONE IDEXX DRIVE, WESTBROOK ME 04092
Martin Alexander Smith officer: Executive Vice President C/O IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Jonathan W Ayers director, officer: President & CEO IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Michael Lane officer: Executive Vice President C/O IDEXX LABORATORIES, INC., WESTBROOK ME 04092
Irene Chang Britt director CAMPBELL SOUP COMPANY, ONE CAMPBELL PLACE, CAMDEN NJ 08103
Bruce L. Claflin director 7035 RIDGE ROAD, HANOVER MD 21076
Samer Abdul Samad director 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Stuart Essig director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Lawrence D Kingsley director C/O IDEX CORPORATION, 630 DUNDEE ROAD, NORTHBROOK IL 60062
Asha Collins director IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
M Anne Szostak director C/O TUPPERWARE BRANDS CORP, 14901 S ORANGE BLOSSOM TR, ORLANDO FL 32837
Sharon E. Underberg officer: EVP, GC & Corporate Secretary EASTMAN KODAK COMPANY, 343 STATE STREET, ROCHESTER NY 14650
Sophie V. Vandebroek director 6 OAK MEADOW ROAD, LINCOLN MA 01770
Daniel M Junius director C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451